Risk factors for surgical site infection in Japanese patients with ulcerative colitis: a multicenter prospective study

Surgery Today
Toshimitsu ArakiMasato Kusunoki

Abstract

A prospective, multicenter, observational study was performed to investigate the risk factors of surgical site infection (SSI) in patients with ulcerative colitis (UC). From 2009 to 2010, perioperative clinicopathological data were collected from patients who had undergone surgery for UC within the research period, for up to 6 consecutive months in 13 hospitals in Japan. The primary outcome was the development of SSI. A total of 195 patients with UC who underwent colorectal surgery were enrolled. SSI was diagnosed in 38 (19.5 %) patients, in the form of incisional infection in 23 (11.8 %), organ/space infection in 16 (8.2 %), and both in 1 (0.5 %). There were no significant risk factors associated with an increased risk of development of incisional SSI. An American Society of Anesthesiologists physical status of ≥ 3 was indicated as the only significant risk factor for organ/space SSI (P = 0.02) compared with other factors, such as a neutrophil count of >100 × 10(2)/mm(3), albumin level of <3.5 g/dl, perioperative packed red blood cell transfusion, fair or poor colonic cleanliness, and therapeutic use of antibiotics. Poor general physical status was the significant independent risk factor for organ/space SSI in patients with UC...Continue Reading

References

Apr 29, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·A J MangramW R Jarvis
Dec 2, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·K B KirklandD J Sexton
Jul 20, 2001·The Journal of Hospital Infection·P AstagneauUNKNOWN INCISO Network Study Group
Jun 4, 2005·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·P Wille-JørgensenA A Castro
Apr 4, 2006·International Journal of Colorectal Disease·Khaled M MadboulyVictor W Fazio
Oct 19, 2006·Journal of Gastroenterology·Hiroki IkeuchiTakayuki Matsumoto
Apr 17, 2007·American Journal of Surgery·Timothy W Bax, M Shane McNevin
Apr 17, 2008·Diseases of the Colon and Rectum·Elizabeth C WickJulio Garcia-Aguilar
Jan 21, 2010·Diseases of the Colon and Rectum·Motoi UchinoYoshio Takesue
Sep 9, 2011·The Cochrane Database of Systematic Reviews·Katia F GüenagaPeer Wille-Jørgensen
Feb 3, 2012·Technology and Health Care : Official Journal of the European Society for Engineering and Medicine·Magnus Friedrich KaffarnikStefan Utzolino
Feb 11, 2012·Journal of the American College of Surgeons·Rajesh PendlimariMarianne Huebner

❮ Previous
Next ❯

Citations

Oct 25, 2020·The Cochrane Database of Systematic Reviews·Cindy Cy LawNeeraj Narula
Oct 29, 2020·PloS One·J M van NiekerkJ E W C van Gemert-Pijnen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.